M Gibaldi. Show Affiliations »
Abstract
Mesh: See more » Administration, OralAnimalsAntineoplastic Agents/bloodAzo Compounds/bloodDapsone/bloodDapsone/urineDogsDrug TherapyHalf-LifeHumansImidazoles/bloodInjections, IntraperitonealInjections, IntravenousInjections, SubcutaneousKineticsLiver/metabolismMathematicsModels, BiologicalPharmaceutical Preparations/administration & dosagePharmaceutical Preparations/bloodPharmaceutical Preparations/metabolismPharmaceutical Preparations/urinePharmacologyPhenytoin/metabolismPropranolol/bloodSalicylates/metabolismTime Factors
Substances: See more » Antineoplastic AgentsAzo CompoundsImidazolesPharmaceutical PreparationsSalicylatesPhenytoinDapsonePropranolol
Year: 1971 PMID: 4936775 DOI: 10.1111/j.1749-6632.1971.tb46888.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691